MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/ana.0000000000000705

Медицинская библиотека · Journal of neurosurgical anesthesiology · 2022

Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study.

Robba Chiara, Aspide Raffaele, Pegoli Marianna, Kondratyeva Ekaterina, Gritti Paolo, Fustini Marco F, Battaglini Denise, Pelosi Paolo, Hutchinson Peter J, Helmy Adel, Bortolotti Carlo, Zenesini Corrado, Bilotta Federico

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage (aSAH) remains incompletely elucidated. Furthermore, it is not clear whether these abnormalities impact patient outcomes. The aim of this study was to evaluate the prevalence of pituitary dysfunction after aSAH and its effect on outcomes.

METHODS

We carried out a prospective, cohort study including adult patients (18 y of age or older) with a diagnosis of aSAH who were admitted to the intensive care unit in 3 centers between January 2017 and January 2019. Exclusion criteria were previous hypopituitarism, hormonal replacement therapies for pituitary dysfunction or any corticosteroid treatment. Endocrine function was tested within the first 48 hours after aSAH onset (acute phase), after 1 to 3 weeks (subacute phase), and after 6 to 12 months (chronic phase). Clinical outcomes were assessed at 6 to 12 months using the modified Rankin Scale.

RESULTS

Fifty-six patients were included in the study; all were studied in the acute phase, 34 were studied in the subacute phase, and 49 in the chronic phase. Pituitary dysfunction was identified in 92.3% (95% confidence interval; [CI]: 86.6%-98.0%) of cases in the acute phase, in 83.3% (95% CI: 70.8%-95.8%) in the subacute phase, and in 83.3% (95% CI: 72.7%-93.9%) of cases in the chronic phase. The most commonly identified abnormality was dysfunction of the pituitary-gonadal axis. There was no correlation between pituitary dysfunction and clinical outcome.

CONCLUSION

Pituitary dysfunction is common after aSAH, but does not affect 6 to 12-month clinical outcomes.

Для цитирования: Robba Chiara, Aspide Raffaele, Pegoli Marianna, Kondratyeva Ekaterina, Gritti Paolo, Fustini Marco F, Battaglini Denise, Pelosi Paolo, Hutchinson Peter J, Helmy Adel, Bortolotti Carlo, Zenesini Corrado, Bilotta Federico. Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study.. Journal of neurosurgical anesthesiology. 2022. DOI: 10.1097/ana.0000000000000705.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.